Open access
Jul 2026
Development and in vitro evaluation of glycyrrhetinic acid and alpha-lipoic acid co-loaded nanophytosomes: a strategy to mitigate cisplatin-induced hepatocellular damage.
The engineered GALP platform addresses the shared biopharmaceutical limitations of GA and ALA, offering a physicochemical profile well-suited for future in vivo pharmacokinetic and liver distribution studies.
Shima Parviz, Negar Azarpira, Z. Zarei-Behjani et al.
· Scientific Reports · 0 citations